English
Back
Download
Log in to access Online Inquiry
Back to the Top

Guangdong Biolight Meditech's low P/S ratio may be due to ex...

Guangdong Biolight Meditech's low P/S ratio may be due to expected revenue decline. The company's shrinking revenue and the industry's projected growth are key factors. Shareholders accept the low P/S, conceding future revenue may not surprise. If revenue trends continue, share price may not move strongly in either direction soon.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
1511 Views
Comment
Sign in to post a comment